Efficacy of Factor Xa Inhibitors Versus Placebo in Thromboprophylaxis for Cancer-Associated Thromboembolism: A Systematic Review and Meta-analysis
Background Cancer patients are at significantly increased risk of venous thromboembolism (VTE), a leading cause of morbidity and mortality in this population. While traditional anticoagulants like low-molecular-weight heparin (LMWH) and vitamin K antagonists (VKAs) are commonly used, their limitatio...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2025-09-01
|
| Col·lecció: | Clinical and Applied Thrombosis/Hemostasis |
| Accés en línia: | https://doi.org/10.1177/10760296251372947 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
